Osivax

Last updated: May 01, 2024

Alexandre Levert - Founder and CEO
Alexandre Levert - Founder and CEO
Country: France | Funding: $59.2M (+)

Website: http://www.osivax.com/

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.